NHS Guidance on GLP-1 Use for Thyroid Conditions The NHS does not recommend GLP-1 receptor agonists for Hashimoto's thyroiditis or any thyroid condition in the absence of type 2 diabetes or obesity meeting NICE eligibility criteria
It enhances insulin secretion, inhibits glucagon release, slows gastric emptying, and decreases hepatic glucose production, leading to improved glycemic control and reduced HbA1c levels
But really we have no idea how this plays out in [pregnant] humans, and we wont have that data for years. Despite the lack of clarity on what this drug could do to women, the concerns have not been relayed in advertising in the US or in media coverage
In subsequent weeks, I did not experience the same intense side effects
They help you lose weight by slowing down gastric emptying, helping you feel fuller for longer and reducing overall caloric intake